1. https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/investor_presentations/2019/20190923%20-%20Rybelsus%20presentation.pdf, Accessed on 10th May 2021.
2. https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/investor_presentations/2020/05052020_Q1%202020%20core%20deck.pdf, Accessed 10th May 2021.
3. https://www.pmlive.com/pharma_news/novo_nordisk_gets_another_ok_for_oral_glp-1_drug_rybelsus_1343323, Accessed 10th May 2021.
4. Lewis AL, Richard J. Ther Deliv. 2015;6(2):149–63.
5. Anselmo AC, Gokarn Y, Mitragotri S. Nat Rev Drug Discov. 2019;18:19–39.